Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1845 1
1866 1
1879 1
1891 4
1893 3
1895 1
1897 1
1898 1
1900 1
1902 1
1903 1
1905 4
1906 1
1907 4
1908 2
1909 3
1910 1
1914 1
1918 1
1923 1
1932 2
1938 1
1939 1
1942 2
1944 1
1945 2
1946 8
1947 8
1948 5
1949 3
1950 4
1951 5
1952 5
1953 3
1954 4
1955 5
1956 5
1957 5
1958 1
1959 5
1961 4
1962 4
1963 3
1964 3
1965 4
1966 13
1967 16
1968 16
1969 9
1970 4
1971 3
1972 1
1973 5
1974 6
1975 7
1976 6
1977 6
1978 4
1979 4
1980 5
1981 5
1982 6
1983 5
1984 7
1985 12
1986 8
1987 9
1988 8
1989 4
1990 5
1991 7
1992 15
1993 11
1994 11
1995 11
1996 8
1997 16
1998 6
1999 11
2000 11
2001 16
2002 13
2003 8
2004 8
2005 10
2006 11
2007 10
2008 11
2009 14
2010 16
2011 6
2012 7
2013 9
2014 8
2015 12
2016 12
2017 14
2018 12
2019 13
2020 21
2021 24
2022 23
2023 25
2024 21
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Results by year

Filters applied: . Clear all
Page 1
Breast ironing.
Robinson F. Robinson F. BMJ. 2019 Apr 23;365:l1790. doi: 10.1136/bmj.l1790. BMJ. 2019. PMID: 31015186 No abstract available.
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Genovese G, Carugo A, Tepper J, Robinson FS, Li L, Svelto M, Nezi L, Corti D, Minelli R, Pettazzoni P, Gutschner T, Wu CC, Seth S, Akdemir KC, Leo E, Amin S, Molin MD, Ying H, Kwong LN, Colla S, Takahashi K, Ghosh P, Giuliani V, Muller F, Dey P, Jiang S, Garvey J, Liu CG, Zhang J, Heffernan TP, Toniatti C, Fleming JB, Goggins MG, Wood LD, Sgambato A, Agaimy A, Maitra A, Roberts CW, Wang H, Viale A, DePinho RA, Draetta GF, Chin L. Genovese G, et al. Among authors: robinson fs. Nature. 2017 Feb 16;542(7641):362-366. doi: 10.1038/nature21064. Epub 2017 Feb 8. Nature. 2017. PMID: 28178232 Free PMC article.
Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinoma.
Chaturantabut S, Oliver S, Frederick DT, Kim JJ, Robinson FP, Sinopoli A, Song TY, He Y, Chang YC, Rodriguez DJ, Chang L, Kesar D, Ching M, Dzvurumi R, Atari A, Tseng YY, Bardeesy N, Sellers WR. Chaturantabut S, et al. Among authors: robinson fp. J Clin Invest. 2025 Feb 27;135(8):e182417. doi: 10.1172/JCI182417. eCollection 2025 Apr 15. J Clin Invest. 2025. PMID: 40014401 Free PMC article.
Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
Lissanu Deribe Y, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran C, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA. Lissanu Deribe Y, et al. Among authors: robinson f. Nat Med. 2018 Jul;24(7):1047-1057. doi: 10.1038/s41591-018-0019-5. Epub 2018 Jun 11. Nat Med. 2018. PMID: 29892061 Free PMC article.
MAP kinases.
Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH. Chen Z, et al. Among authors: robinson f. Chem Rev. 2001 Aug;101(8):2449-76. doi: 10.1021/cr000241p. Chem Rev. 2001. PMID: 11749383 Review. No abstract available.
Radiation-associated prolactinoma.
Cohen PR, Robinson FW, Gray JM. Cohen PR, et al. Among authors: robinson fw. South Med J. 2011 Jan;104(1):71-2. doi: 10.1097/SMJ.0b013e3181eda231. South Med J. 2011. PMID: 21079539 No abstract available.
Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinoma.
Chaturantabut S, Oliver S, Frederick DT, Kim J, Robinson FP, Sinopoli A, Song TY, Rodriguez DJ, Chang L, Kesar D, He Y, Ching M, Dzvurumi R, Atari A, Tseng YY, Bardeesy N, Sellers WR. Chaturantabut S, et al. Among authors: robinson fp. bioRxiv [Preprint]. 2024 Sep 18:2024.09.16.613045. doi: 10.1101/2024.09.16.613045. bioRxiv. 2024. Update in: J Clin Invest. 2025 Feb 27;135(8):e182417. doi: 10.1172/JCI182417. PMID: 39345400 Free PMC article. Updated. Preprint.
716 results